NCT00227630View on ClinicalTrials.gov

Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

August 31, 2007

Conditions
Malignant Mesothelioma
Interventions
DRUG

cisplatin

DRUG

pemetrexed disodium

PROCEDURE

adjuvant therapy

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

RADIATION

radiation therapy

Trial Locations (8)

16132

Istituto Nazionale per la Ricerca sul Cancro, Genoa

33100

Universita Degli Studi di Udine, Udine

43100

Azienda Ospedaliera Di Parma, Parma

B-2650

Universitair Ziekenhuis Antwerpen, Edegem

3435 CM

Sint Antonius Ziekenhuis, Nieuwegein

3008 AE

Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam

HU8 9HE

Princess Royal Hospital at Hull and East Yorkshire NHS Trust, Hull

EH4 2XU

Edinburgh Cancer Centre at Western General Hospital, Edinburgh

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00227630 - Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma | Biotech Hunter | Biotech Hunter